Results 171 to 180 of about 21,823 (203)
Some of the next articles are maybe not open access.
Drugs, 1999
Valsartan/hydrochlorothiazide (HCTZ) combines an angiotensin II AT1 receptor blocker with a thiazide diuretic to produce additive blood pressure reductions without major effects on heart rate. HCTZ did not significantly alter valsartan pharmacokinetics; during combination therapy, HCTZ pharmacokinetics differed from those seen with HCTZ monotherapy. In
H D, Langtry, K J, McClellan
openaire +2 more sources
Valsartan/hydrochlorothiazide (HCTZ) combines an angiotensin II AT1 receptor blocker with a thiazide diuretic to produce additive blood pressure reductions without major effects on heart rate. HCTZ did not significantly alter valsartan pharmacokinetics; during combination therapy, HCTZ pharmacokinetics differed from those seen with HCTZ monotherapy. In
H D, Langtry, K J, McClellan
openaire +2 more sources
Escitalopram/hydrochlorothiazide/losartan/hydrochlorothiazide
Reactions Weekly, 2020openaire +1 more source
Hydrochlorothiazide see Methyldopa/hydrochlorothiazide
Reactions Weekly, 1990openaire +1 more source
Hydrochlorothiazide see Triamterene + hydrochlorothiazide
Reactions Weekly, 1990openaire +1 more source